Dr. Trump Ph . D. in epidemiologySavage sciences make him uniquely qualified to comment on some of the Savage of the American medical system , but most interestingly , his chapter on health care focuses on what was Savage with the system before Obamacare .The FDA is a primary target for Savage , who makes the case that Trump must overhaul the agency to lower costs and promote competition amongst pharmaceutical companies .He illustrates this argument with the example of Mylan Savage EpiPen , the price of which rose 540 percent over nine years .